Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8680270
SERIAL NO

12515676

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The presently disclosed subject matter is directed to metallo-oxidoreductase inhibitors having metal binding moities linked to a targeting moiety through a linking group or a direct bond, methods for screening for metallo-oxidoreductase inhibitors, and methods of treating an oxidoreductase related disorder by administering a metallo-oxidoreductase inhibitor to a subject in need of treatment thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VIAMET PHARMACEUTICALS HOLDINGS LLC4505 EMPEROR BLVD DURHAM NC 27703

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hoekstra, William J Chapel Hill, US 85 1097
Schotzinger, Robert J Raleigh, US 29 696

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 25, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00